| Particulars |
|
|
|
|
Company Name
| Piramal Pharma Ltd
|
Year End
| 202603
|
| Full Year |
| Equity (₹ Cr.) |
1,331.35 |
B.V. (₹) |
63.50 |
| Sales(₹ Cr.) |
4,782.01 |
NP (₹ Cr.) |
767.53 |
| NP Var% |
11.00 |
Div% |
0.00 |
| CPS(₹) |
7.70 |
EPS (₹) |
5.80 |
| Traded Value(₹ Lakhs) |
705.62 |
52 Week High |
250.00 |
| 52 Week Low |
133.00 |
Price BSE |
245.00 |
| Price NSE |
245.00 |
Market Capital (₹ Cr.) |
32,571.43 |
| P/C Ratio |
31.90 |
P/E Ratio |
42.50 |
| Price Vs.BV |
3.86 |
|
| Latest Quarter |
| Year End |
202609 |
Sales (₹ Cr.) |
1,345.38 |
| NP(₹ Cr.) |
170.74 |
NP Var % |
-13.00 |
| Trailing Twelve Months |
| Year End |
202609 |
Sales |
4,897.03 |
| OPM |
20.67 |
NP |
642.75 |
| NP Var% |
6.14 |
EPS |
5.62 |
| PE |
43.53 |
|
|